ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
36.96B
Market cap36.96B
Price-Earnings ratio
25.82
Price-Earnings ratio25.82
Dividend yield
0.90%
Dividend yield0.90%
Average volume
860.40K
Average volume860.40K
High today
$252.93
High today$252.93
Low today
$250.42
Low today$250.42
Open price
$252.93
Open price$252.93
Volume
916.50K
Volume916.50K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

ResMed(RMD) stock is priced at $250.69, giving the company a market capitalization of 36.96B. It carries a P/E multiple of 25.82 and pays a dividend yield of 89.6%.

On 2025-12-14, ResMed(RMD) stock traded between a low of $250.42 and a high of $252.93. Shares are currently priced at $250.69, which is +0.1% above the low and -0.9% below the high.

The ResMed(RMD)'s current trading volume is 916.5K, compared to an average daily volume of 860.4K.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

During the past year, ResMed(RMD) stock moved between $199.92 at its lowest and $293.81 at its peak.

RMD News

Simply Wall St 1d
How FDA-Cleared AI Smart Comfort Personalization At ResMed Has Changed Its Investment Story

In December 2025, ResMed announced it had received U.S. FDA clearance for Smart Comfort, an AI-enabled feature that uses more than 100 million nights of de-iden...

How FDA-Cleared AI Smart Comfort Personalization At ResMed Has Changed Its Investment Story
TipRanks 5d
ResMed CEO Reports Strategic Stock Transactions

TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...

TipRanks 6d
ResMed receives FDA clearance for PTCS to be marketed as Smart Comfort

Resmed (RMD) announced it has received U.S. Food and Drug Administration, FDA, clearance for Personalized Therapy Comfort Settings, PTCS, to be marketed as Smar...

Analyst ratings

76%

of 29 ratings
Buy
75.9%
Hold
20.7%
Sell
3.4%

More RMD News

Barchart 6d
Is ResMed Stock Underperforming the S&P 500?

With a market cap of $37.4 billion , San Diego, California-based ResMed Inc. ( RMD ) develops and markets medical devices and cloud-based software for diagnosin...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.